ArticleOncotarget2017

Integrative bioinformatics analysis identifies ROBO1 as a potential therapeutic target modified by miR-218 in hepatocellular carcinoma.

Junqing Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.